title: MicroRNAs in lung diseases.
abstract: The advent of RNA sequencing technology has stimulated rapid advances in our understanding of the transcriptome, including discovery of the vast RNA complement generated by transcript splice variation and the expansion of our knowledge of non-coding RNAs. One non-coding RNA subtype, microRNAs (miRNAs), are particularly well studied, primarily because of their important roles as post-transcriptional gene regulators. The first miRNA was identified in the early 1990s and there are now thought to be around 1000 distinct miRNAs in man, with each cell type expressing a distinct repertoire. Increasing evidence has implicated miRNAs as having causative roles in a variety of lung diseases and has driven investigations into their potential as therapeutic targets.
authors.affiliation: Department of Asthma, Allergy and Respiratory Science, MRC/Asthma UK Centre in Allergic Mechanisms of Asthma, King’s College London, Guy’s Hospital, London, UK.
authors.forename: Tom
authors.initials: T
authors.lastname: Pagdin
authors.forename: Paul
authors.initials: P
authors.lastname: Lavender
mesh_terms: D000818:Animals; D001249:Asthma / Q000235:genetics; D004195:Disease Models, Animal; D005786:Gene Expression Regulation; D006801:Humans; D008171:Lung Diseases / Q000235:genetics*; D008175:Lung Neoplasms / Q000235:genetics; D051379:Mice; D035683:MicroRNAs / Q000235:genetics*; D029424:Pulmonary Disease, Chronic Obstructive / Q000235:genetics; D011658:Pulmonary Fibrosis / Q000235:genetics
chemical_list: D035683:MicroRNAs